All Stories

  1. MR1 presents vitamin B6–related compounds for recognition by MR1-reactive T cells
  2. Acute experimental infection of bats and ferrets with Hendra virus: Insights into the early host response of the reservoir host and susceptible model species
  3. Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response
  4. Employing proteomics in the study of antigen presentation: an update
  5. Immunopeptidomics Special Issue
  6. Inability To Detect Cross-Reactive Memory T Cells Challenges the Frequency of Heterologous Immunity among Common Viruses
  7. Reply to Roudieret al.: HLA-DRB1 polymorphism, anti-citrullinated protein antibodies, and rheumatoid arthritis
  8. Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics
  9. In Immunopeptidomics We Need a Sniper Instead of a Shotgun
  10. Structural and regulatory diversity shape HLA-C protein expression levels
  11. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
  12. Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed Necrosis
  13. Hormone-like peptides in the venoms of marine cone snails
  14. HIVed, a knowledgebase for differentially expressed human genes and proteins during HIV infection, replication and latency
  15. MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape
  16. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells
  17. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype
  18. CD1a on Langerhans cells controls inflammatory skin disease
  19. Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology!
  20. A prominent role of PDIA6 in processing of misfolded proinsulin
  21. Conserved Features in the Structure, Mechanism, and Biogenesis of the Inverse Autotransporter Protein Family
  22. Characterization of the Antigen Processing Machinery and Endogenous Peptide Presentation of a Bat MHC Class I Molecule
  23. Rapid expansion of the protein disulfide isomerase gene family facilitates the folding of venom peptides
  24. Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
  25. Human Leukocyte Antigen (HLA) B27 Allotype-Specific Binding and Candidate Arthritogenic Peptides Revealed through Heuristic Clustering of Data-independent Acquisition Mass Spectrometry (DIA-MS) Data
  26. Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
  27. A Naturally Occurring Peptide with an Elementary Single Disulfide-Directed β-Hairpin Fold
  28. A Systems Approach to Understand Antigen Presentation and the Immune Response
  29. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii
  30. Quantifying epitope presentation using mass spectrometry
  31. Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells
  32. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex
  33. An open-source computational and data resource to analyze digital maps of immunopeptidomes
  34. Assembly of the secretion pores GspD, Wza and CsgG into bacterial outer membranes does not require the Omp85 proteins BamA or TamA
  35. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
  36. A comprehensive analysis of peptides presented by HLA-A1
  37. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells
  38. Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry
  39. Revisiting the Arthritogenic Peptide Theory: Quantitative Not Qualitative Changes in the Peptide Repertoire of HLA-B27 Allotypes
  40. Pancreatic Beta Cells Are Highly Susceptible to Oxidative and ER Stresses during the Development of Diabetes
  41. Specialized insulin is used for chemical warfare by fish-hunting cone snails
  42. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
  43. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides
  44. Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venom
  45. An Extensive Antigenic Footprint Underpins Immunodominant TCR Adaptability against a Hypervariable Viral Determinant
  46. Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer–Restricted CD4+T Cells Infiltrate Islets in Type 1 Diabetes
  47. The Cellular Redox Environment Alters Antigen Presentation
  48. Using mass spectrometry to monitor drug induced changes in antigen presentation by the human leukocyte antigen
  49. A mortise–tenon joint in the transmembrane domain modulates autotransporter assembly into bacterial outer membranes
  50. Structural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell Epitopes
  51. A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism
  52. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients
  53. Diversity of Conotoxin Gene Superfamilies in the Venomous Snail, Conus victoriae
  54. Combined Proteomic and Transcriptomic Interrogation of the Venom Gland of Conus geographus Uncovers Novel Components and Functional Compartmentalization
  55. A comprehensive analysis of constitutive naturally processed and presentedHLA-C*04:01(Cw4) - specific peptides
  56. Quantitative proteomic profiling reveals novel region-specific markers in the adult mouse brain
  57. The Beta Cell Immunopeptidome
  58. Discovery of Novel Disease-specific and Membrane-associated Candidate Markers in a Mouse Model of Multiple Sclerosis
  59. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis
  60. High molecular weight components of the injected venom of fish-hunting cone snails target the vascular system
  61. HLA Peptide Length Preferences Control CD8+ T Cell Responses
  62. Highly Divergent T-cell Receptor Binding Modes Underlie Specific Recognition of a Bulged Viral Peptide bound to a Human Leukocyte Antigen Class I Molecule
  63. Preemptive priming readily overcomes structure-based mechanisms of virus escape
  64. Human leukocyte antigen-associated drug hypersensitivity
  65. Kinetics of Antigen Expression and Epitope Presentation during Virus Infection
  66. Membrane proteomics by high performance liquid chromatography-tandem mass spectrometry: Analytical approaches and challenges
  67. Assembly of the Type II Secretion System such as Found in Vibrio cholerae Depends on the Novel Pilotin AspS
  68. Novel Tumor Derived Peptides in Vaccines
  69. Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis
  70. The Use of Proteomics to Dissect the Molecular Specificities of T Cells in Type 1 Diabetes
  71. MR1 presents microbial vitamin B metabolites to MAIT cells
  72. Biased T Cell Receptor Usage Directed against Human Leukocyte Antigen DQ8-Restricted Gliadin Peptides Is Associated with Celiac Disease
  73. Modulation of Conotoxin Structure and Function Is Achieved through a Multienzyme Complex in the Venom Glands of Cone Snails
  74. Constitutive and Inflammatory Immunopeptidome of Pancreatic  -Cells
  75. Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?
  76. Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands
  77. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
  78. Immune self-reactivity triggered by drug-modified human leukocyte antigen-peptide presentation
  79. Discovery of an archetypal protein transport system in bacterial outer membranes
  80. Tracking protein aggregation and mislocalization in cells with flow cytometry
  81. The Energetic Basis Underpinning T-cell Receptor Recognition of a Super-bulged Peptide Bound to a Major Histocompatibility Complex Class I Molecule
  82. Drug Hypersensitivity and Human Leukocyte Antigens of the Major Histocompatibility Complex
  83. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles
  84. A Structural Basis for Varied    TCR Usage against an Immunodominant EBV Antigen Restricted to a HLA-B8 Molecule
  85. CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells
  86. Specialisation of the Venom Gland Proteome in Predatory Cone Snails Reveals Functional Diversification of the Conotoxin Biosynthetic Pathway
  87. Defining the Substrate Specificity Determinants Recognized by the Active Site of C-Terminal Src Kinase-Homologous Kinase (CHK) and Identification of β-Synuclein as a Potential CHK Physiological Substrate
  88. Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8 + T-cell responses
  89. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring
  90.  2-Glycoprotein I and Protection from Anti-SSA/Ro60-Associated Cardiac Manifestations of Neonatal Lupus
  91. Embryonic Toxin Expression in the Cone Snail Conus victoriae: PRIMED TO KILL OR DIVERGENT FUNCTION?
  92. Linear ubiquitination prevents inflammation and regulates immune signalling
  93. Experimental autoimmune encephalomyelitis (EAE) IN C57Bl/6 mice is not associated with astrogliosis
  94. Peptidomimetics: modifying peptides in the pursuit of better vaccines
  95. Stable isotope shifted matrices enable the use of low mass ion precursor scanning for targeted metabolite identification
  96. A novel strategy for the targeted analysis of protein and peptide metabolites
  97. Proteomic Interrogation of Venom Delivery in Marine Cone Snails: Novel Insights into the Role of the Venom Bulb
  98. The structural basis for autonomous dimerization of the pre-T-cell antigen receptor
  99. Epitope Discovery and Their Use in Peptide Based Vaccines
  100. Protective Efficacy of Cross-Reactive CD8+ T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation Threshold
  101. Allelic polymorphism in the T cell receptor and its impact on immune responses
  102. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability
  103. Constraints within major histocompatibility complex class I restricted peptides: Presentation and consequences for T-cell recognition
  104. Identification of Conus Peptidylprolyl Cis-Trans Isomerases (PPIases) and Assessment of Their Role in the Oxidative Folding of Conotoxins
  105. Enhancing tumor vaccines: catalyzing MHC class II peptide exchange
  106. Reactivity with dichotomous determinants of Ro 60 stratifies autoantibody responses in lupus and primary Sjögren's syndrome
  107. A Modular BAM Complex in the Outer Membrane of the α-Proteobacterium Caulobacter crescentus
  108. Rapid microscale in-gel processing and digestion of proteins using surface acoustic waves
  109. Molecular Markers of Preterm Labor in the Choriodecidua
  110. T Cell Allorecognition via Molecular Mimicry
  111. Post-translationally modified T cell epitopes: immune recognition and immunotherapy
  112. The Protein Import Channel in the Outer Mitosomal Membrane of Giardia intestinalis
  113. Antigen Ligation Triggers a Conformational Change within the Constant Domain of the αβ T Cell Receptor
  114. Correction: Article on Vaccination Reveals a Long Dominant CTL Epitope
  115. The A-chain of insulin is a hot-spot for CD4+T cell epitopes in human type 1 diabetes
  116. Mass Spectral Identification of Vc1.1 and Differential Distribution of Conopeptides in the Venom Duct of Conus victoriae. Effect of Post-Translational Modifications and Disulfide Isomerisation on Bioactivity
  117. Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes
  118. The Shaping of T Cell Receptor Recognition by Self-Tolerance
  119. A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design
  120. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition
  121. Complete modification of TCR specificity and repertoire selection does not perturb a CD8 + T cell immunodominance hierarchy
  122. Can α- and β-Alanine Containing Peptides Be Distinguished Based on the CID Spectra of Their Protonated Ions?
  123. Protein secretion and outer membrane assembly in Alphaproteobacteria
  124. Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
  125. T-cells behaving badly: structural insights into alloreactivity and autoimmunity
  126. Refinement in the production and purification of recombinant HCMV IE1–pp65 protein for the generation of epitope-specific T cell immunity
  127. The Enantioselective Total Synthesis and Unambiguous Proof of the Absolute Stereochemistry of Pervilleine C
  128. Impact of glycans on T‐cell tolerance to glycosylated self‐antigens
  129. Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
  130. Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
  131. Structural and Biological Basis of CTL Escape in Coronavirus-Infected Mice
  132. Epitope-specific TCRβ repertoire diversity imparts no functional advantage on the CD8+T cell response to cognate viral peptides
  133. Molecular machinations of the MHC-I peptide loading complex
  134. Immunodominance Hierarchies and Gender Bias in Direct TCD8-Cell Alloreactivity
  135. β-Amino Acid-Containing Hybrid Peptides — New Opportunities in Peptidomimetics.
  136. The molecular basis of cross-reactivity in the Australian Snake Venom Detection Kit (SVDK)
  137. Expression and purification of the minor histocompatibility antigen, HA-1H generated in Escherichia coli
  138. A Structural and Immunological Basis for the Role of Human Leukocyte Antigen DQ8 in Celiac Disease
  139. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients
  140. More than one reason to rethink the use of peptides in vaccine design
  141. Mass Spectrometric Applications in Immunoproteomics
  142. Conserved Motifs Reveal Details of Ancestry and Structure in the Small TIM Chaperones of the Mitochondrial Intermembrane Space
  143. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule
  144. β-Amino acid-containing hybrid peptides—new opportunities in peptidomimetics
  145. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP
  146. Tumors reveal their secrets to cytotoxic T cells
  147. C-terminal Src Kinase-homologous Kinase (CHK), a Unique Inhibitor Inactivating Multiple Active Conformations of Src Family Tyrosine Kinases
  148. Disparate thermodynamics governing T cell receptor–MHC-I interactions implicate extrinsic factors in guiding MHC restriction
  149. Su.31. An Enigmatic Human Cd4+ T-Cell Epitope in the C-Peptide of Proinsulin
  150. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation
  151. The insulin A-chain epitope recognized by human T cells is posttranslationally modified
  152. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptide
  153. T Cell Determinants Incorporating  -Amino Acid Residues Are Protease Resistant and Remain Immunogenic In Vivo
  154. CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection
  155. Qualitative and Quantitative Differences in Peptides Bound to HLA-B27 in the Presence of Mouse versus Human Tapasin Define a Role for Tapasin as a Size-Dependent Peptide Editor
  156. Use of proteomics to define targets of T-cell immunity
  157. An emerging role for comprehensive proteome analysis in human pregnancy research
  158. High Resolution Structures of Highly Bulged Viral Epitopes Bound to Major Histocompatibility Complex Class I
  159. Antagonism of Antiviral and Allogeneic Activity of a Human Public CTL Clonotype by a Single Altered Peptide Ligand: Implications for Allograft Rejection
  160. Lack of prominent peptide–major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations
  161. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition
  162. A Charged Amino Acid Residue in the Transmembrane/Cytoplasmic Region of Tapasin Influences MHC Class I Assembly and Maturation
  163. TAP genes and immunity
  164. The production and purification of the human T-cell receptors, the CD3∊γ and CD3∊δ heterodimers: complex formation and crystallization with OKT3, a therapeutic monoclonal antibody
  165. Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion
  166. The Structure of H-2Kb and Kbm8 Complexed to a Herpes Simplex Virus Determinant: Evidence for a Conformational Switch That Governs T Cell Repertoire Selection and Viral Resistance
  167. Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3
  168. Predisposition to abacavir hypersensitivity conferred byHLA-B*5701and a haplotypicHsp70-Homvariant
  169. Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue
  170. Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response
  171. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells
  172. Optimisation of peptide-based cytotoxic T-cell determinants using
  173. Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin
  174. Human T-cells recognise N-terminally Fmoc-modified peptide
  175. Preface: Peptides —From discovery to therapeutics
  176. Optimisation of peptide-based cytotoxic T-cell determinants using non-natural amino acids
  177. A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition
  178. Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity?
  179. A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity
  180. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design
  181. Identification of an I-Adrestricted peptide on the 65-kilodalton heat shock protein ofMycobacterium avium
  182. The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state
  183. The 1.5 Å Crystal Structure of a Highly Selected Antiviral T Cell Receptor Provides Evidence for a Structural Basis of Immunodominance
  184. The Structure of HLA-B8 Complexed to an Immunodominant Viral Determinant: Peptide-Induced Conformational Changes and a Mode of MHC Class I Dimerization
  185. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex
  186. Restricted Specificity of Intermolecular Spreading to Endogenous La (SS-B) and 60 kDa Ro (SS-A) in Experimental Autoimmunity
  187. Optimization of the MHC Class I Peptide Cargo Is Dependent on Tapasin
  188. The Central Role Played by Peptides in the Immune Response and the Design of Peptide-Based Vaccines Against Infectious Diseases and Cancer
  189. The use of post-source decay in matrix-assisted laser desorption/ionisation mass spectrometry to delineate T cell determinants
  190. Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire
  191. Tapasin-Mediated Retention and Optimization of Peptide Ligands During the Assembly of Class I Molecules
  192. The peptide-loading complex and ligand selection during the assembly of HLA class I molecules
  193. Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant APC
  194. The Biology of Major Histocompatibility Complex Molecules—II: Antigen Processing and Presentation
  195. Comparison between the isocratic and gradient retention behaviour of polypeptides in reversed-phase liquid chromatographic environments
  196. Probing the Binding Behavior and Conformational States of Globular Proteins in Reversed-Phase High-Performance Liquid Chromatography
  197. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice
  198. RP-HPLC Binding Domains of Proteins
  199. Determinant spreading: lessons from animal models and human disease
  200. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity
  201. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice
  202. The Accessibility of the Prosthetic Group Biotin during Monomeric Avidin Affinity Chromatography
  203. Nonprecipitating Anti-La(SS-B) Autoantibodies in Primary Sjögren's Syndrome
  204. Conformational effects in reversed-phase high-performance liquid chromatography of polypeptides II. The role of insulin A and B chains in the chromatographic behaviour of insulin
  205. Conformational effects in reversed-phase high-performance liquid chromatography of polypeptides I. Resolution of insulin variants
  206. High-performance liquid chromatography of amino acids, peptides, and proteins. 123. Dynamics of peptides in reversed-phase high-performance liquid chromatography
  207. High-performance liquid chromatography of amino acids, peptides and proteins CXV. Thermodynamic behaviour of peptides in reversed-phase chromatography
  208. High-performance liquid chromatography of amino acids, peptides and proteins
  209. High-performance liquid chromatography of amino acids, peptides and proteins
  210. Isolation and Characterization of Naturally Processed MHC-Bound Peptides From the Surface of Antigen-Presenting Cells